Patel Chem Specialities Limited (BOM:544460)

Market Cap	1.44B
Revenue (ttm)	1.16B +41.0%
Net Income	114.70M +49.8%
EPS	5.67 +26.0%
Shares Out	24.87M
PE Ratio	10.19
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	67,200
Average Volume	46,160
Open	60.70
Previous Close	58.87
Day's Range	56.10 - 60.70
52-Week Range	57.70 - 120.89
Beta	n/a
RSI	30.87
Earnings Date	Apr 15, 2026

About Patel Chem Specialities

Patel Chem Specialities Limited manufactures and sells cellulose-based excipients. It offers sodium monochloro acetate; BlowTab, a sodium starch glycolate; Disolwell, a croscaremellose sodium; Swellcal, a carboxymethyl cellulose calcium; Rheollose, a sodium carboxymethyl cellulose; and Hindcell, a microcrystalline cellulose. The company also provides PharLub magnesium stearate, AmyloTab C pregelatinized starcg, and sodium chloro acetate. Its products are used in pharmaceutical, textile, agriculture, surfactants and detergents, food and beverage...

• Industry: Chemicals and Allied Products
• Founded: 2008
• Employees: 136
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544460

Financial Performance

In fiscal year 2025, Patel Chem Specialities's revenue was 1.05 billion, an increase of 27.59% compared to the previous year's 823.62 million. Earnings were 105.65 million, an increase of 38.00%.